Drug Type Small molecule drug |
Synonyms GSK 214096, GSK214096 |
Target |
Action antagonists |
Mechanism CCR5 antagonists(C-C chemokine receptor type 5 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H46Cl2FN5O3S |
InChIKeyQPEQCSWZPFYDLT-BKHFGAQXSA-N |
CAS Registry716354-87-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | United States | 23 Oct 2008 |